Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page
- CheckyesterdayChange DetectedA new Revision: v3.5.5 tag was added, and several related-topic/navigation items were removed (including Melanoma, related topics:, and MedlinePlus Genetics), as well as the older Revision: v3.5.4 tag. This reflects a footer/navigation cleanup rather than any modification to the study content.SummaryDifference0.2%

- Check8 days agoChange DetectedThe page now includes explicit melanoma keywords and a MedlinePlus related topics entry. This addition helps users understand the study's focus and access related information more easily.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new Revision: v3.5.4 tag was added, and references to Melanoma, related topics, MedlinePlus Genetics, and Revision: v3.5.3 were removed, indicating a refresh of the page's versioning and topic references.SummaryDifference0.2%

- Check29 days agoChange DetectedNo textual changes were detected in the supplied change data; the page content appears unchanged based on the information given.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now includes related topic links for Melanoma and MedlinePlus Genetics in the MedlinePlus related topics section, providing quick access to consumer health information.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page’s footer revision/version was updated to **v3.5.3**. This reflects a metadata/version update rather than a substantive change to the trial information.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.